Literature DB >> 32941930

Recent advances in colon drug delivery systems.

Roberto Arévalo-Pérez1, Cristina Maderuelo2, José M Lanao3.   

Abstract

As a result of its ability to target certain drugs and/or peptides to the colonic region for the treatment of several diseases while avoiding systemic absorption and potential side effects, colon drug delivery has become a field of research of growing interest. Developing new pharmaceutical formulations capable of reaching the colon requires a broad knowledge of natural and synthetic/semisynthetic polymers. Chitosan, polyethylene-oxide, hydroxypropyl methylcellulose, pectin, natural gums, alginates and polymethacrylates have shown promise when applied in the development of colon drug delivery systems, which range from classic formulation strategies such as tablets and capsules to more sophisticated approaches like nanosystems and integrated osmotic-like formulations. This work aims to bring together knowledge regarding the materials and processes used in the development of such pharmaceutical formulations, as well as to highlight recent advances in the field.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon targeted drug delivery; Multiparticulate systems; Nanosystems; Oral administration; Polymers; Polysaccharides

Mesh:

Substances:

Year:  2020        PMID: 32941930     DOI: 10.1016/j.jconrel.2020.09.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Natascia Mennini
Journal:  Mar Drugs       Date:  2022-05-20       Impact factor: 6.085

2.  Poly(curcumin β-amino ester)-Based Tablet Formulation for a Sustained Release of Curcumin.

Authors:  Vinod S Patil; Benjamin C Burdette; J Zach Hilt; Douglass S Kalika; Thomas D Dziubla
Journal:  Gels       Date:  2022-05-30

3.  "Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis.

Authors:  Jiaxin Zhang; Ante Ou; Xueping Tang; Rong Wang; Yujuan Fan; Yuefei Fang; Yuge Zhao; Pengfei Zhao; Dongying Chen; Bing Wang; Yongzhuo Huang
Journal:  J Nanobiotechnology       Date:  2022-08-30       Impact factor: 9.429

Review 4.  Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment.

Authors:  Wunan Zhang; Cecilia Bohns Michalowski; Ana Beloqui
Journal:  Front Bioeng Biotechnol       Date:  2021-06-03

5.  An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.

Authors:  Shangyong Li; Mengfei Jin; Yanhong Wu; Samil Jung; Dandan Li; Ningning He; Myeong-Sok Lee
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

6.  The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.

Authors:  Adrian Rump; Franziska N Weiss; Louisa Schulz; Marie-Luise Kromrey; Eberhard Scheuch; Mladen V Tzvetkov; Tyler White; Shane Durkee; Kevin W Judge; Vincent Jannin; Aouatef Bellamine; Werner Weitschies; Michael Grimm
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.